Literature DB >> 22067963

Parkinson disease: the enteric nervous system spills its guts.

P Derkinderen1, T Rouaud, T Lebouvier, S Bruley des Varannes, M Neunlist, R De Giorgio.   

Abstract

Lewy pathology in Parkinson disease (PD) extends well beyond the CNS, also affecting peripheral autonomic neuronal circuits, especially the enteric nervous system (ENS). The ENS is an integrative neuronal network also referred to as "the brain in the gut" because of its similarities to the CNS. We have recently shown that the ENS can be readily analyzed using routine colonic biopsies. This led us to propose that the ENS could represent a unique window to assess the neuropathology in living patients with PD. In this perspective, we discuss current evidence which indicates that the presence of ENS pathology may by exploited to improve our understanding and management of PD and likely other neurodegenerative disorders.

Entities:  

Mesh:

Year:  2011        PMID: 22067963     DOI: 10.1212/WNL.0b013e318236ef60

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  41 in total

1.  Alpha-synuclein expression patterns in the colonic submucosal plexus of the aging Fischer 344 rat: implications for biopsies in aging and neurodegenerative disorders?

Authors:  R J Phillips; F N Martin; C N Billingsley; T L Powley
Journal:  Neurogastroenterol Motil       Date:  2013-06-30       Impact factor: 3.598

2.  LRRK2 Expression in the Enteric Nervous System: ENSuring Its Significance.

Authors:  Pascal Derkinderen
Journal:  Dig Dis Sci       Date:  2017-04       Impact factor: 3.199

Review 3.  [Translational research in geriatrics? A plea based on current biomedical key publications].

Authors:  L C Bollheimer; D Volkert; T Bertsch; J Bauer; J Klucken; C C Sieber; R Büttner
Journal:  Z Gerontol Geriatr       Date:  2013-08       Impact factor: 1.281

4.  Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.

Authors:  Luca Toti; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-02       Impact factor: 4.052

5.  Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease.

Authors:  Naomi P Visanji; Connie Marras; Drew S Kern; Amaal Al Dakheel; Andrew Gao; Louis W C Liu; Anthony E Lang; Lili-Naz Hazrati
Journal:  Neurology       Date:  2015-02-10       Impact factor: 9.910

6.  Risk of Parkinson's disease after colectomy: longitudinal follow-up study using a national sample cohort.

Authors:  Young-Ju Kim; Chang-Min Lee; Seongheon Kim; Jae-Won Jang; Seo-Young Lee; Seung-Hwan Lee
Journal:  J Neurol       Date:  2019-11-05       Impact factor: 4.849

Review 7.  Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord       Date:  2018-03       Impact factor: 10.338

Review 8.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

9.  Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

Authors:  Min Shi; Changqin Liu; Travis J Cook; Kristin M Bullock; Yanchun Zhao; Carmen Ginghina; Yanfei Li; Patrick Aro; Romel Dator; Chunmei He; Michael J Hipp; Cyrus P Zabetian; Elaine R Peskind; Shu-Ching Hu; Joseph F Quinn; Douglas R Galasko; William A Banks; Jing Zhang
Journal:  Acta Neuropathol       Date:  2014-07-06       Impact factor: 17.088

10.  Macrophages are unsuccessful in clearing aggregated alpha-synuclein from the gastrointestinal tract of healthy aged Fischer 344 rats.

Authors:  Robert J Phillips; Cherie N Billingsley; Terry L Powley
Journal:  Anat Rec (Hoboken)       Date:  2013-02-26       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.